Jiajun Cui

1.1k total citations
39 papers, 823 citations indexed

About

Jiajun Cui is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiajun Cui has authored 39 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Jiajun Cui's work include Estrogen and related hormone effects (5 papers), RNA Interference and Gene Delivery (3 papers) and MicroRNA in disease regulation (3 papers). Jiajun Cui is often cited by papers focused on Estrogen and related hormone effects (5 papers), RNA Interference and Gene Delivery (3 papers) and MicroRNA in disease regulation (3 papers). Jiajun Cui collaborates with scholars based in China, United States and Singapore. Jiajun Cui's co-authors include Chuanfu Zhang, Yutao Yang, Hongbin Song, Xiaoting Zhang, Kai Qian, Xuelin Liu, Jiang Wang, Tianying Wu, Shao‐Chun Wang and Jia Luo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Jiajun Cui

38 papers receiving 812 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiajun Cui China 18 475 217 143 111 96 39 823
Lei Wan China 17 495 1.0× 218 1.0× 113 0.8× 144 1.3× 72 0.8× 107 1.0k
Nan Jia China 19 831 1.7× 247 1.1× 188 1.3× 60 0.5× 111 1.2× 52 1.2k
Xiaofei Zhang China 13 344 0.7× 223 1.0× 143 1.0× 79 0.7× 91 0.9× 32 660
Yihan Zhang China 13 574 1.2× 269 1.2× 88 0.6× 84 0.8× 80 0.8× 54 805
Ángeles Carlos‐Reyes Mexico 13 549 1.2× 254 1.2× 200 1.4× 95 0.9× 61 0.6× 31 908
Sutapa Sinha United States 20 380 0.8× 108 0.5× 130 0.9× 248 2.2× 73 0.8× 43 908
Jean‐Pierre Couty France 16 417 0.9× 108 0.5× 248 1.7× 204 1.8× 59 0.6× 29 1.1k
Junrong Wang China 12 302 0.6× 152 0.7× 138 1.0× 61 0.5× 38 0.4× 36 568

Countries citing papers authored by Jiajun Cui

Since Specialization
Citations

This map shows the geographic impact of Jiajun Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiajun Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiajun Cui more than expected).

Fields of papers citing papers by Jiajun Cui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiajun Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiajun Cui. The network helps show where Jiajun Cui may publish in the future.

Co-authorship network of co-authors of Jiajun Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Jiajun Cui. A scholar is included among the top collaborators of Jiajun Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiajun Cui. Jiajun Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cui, Jiajun, et al.. (2025). Chitosan-decorated silibinin-hyaluronic acid conjugate for enhancing intestinal absorption and improving liver fibrosis. International Journal of Biological Macromolecules. 320(Pt 4). 146057–146057. 2 indexed citations
2.
Liu, Wanqing, Mian Cao, Jiajun Cui, et al.. (2025). Epigenetic regulation-mediated disorders in dopamine transporter endocytosis: A novel mechanism for the pathogenesis of Parkinson's disease. Theranostics. 15(6). 2250–2278. 6 indexed citations
3.
Zheng, Xin, Xinyi Tang, Haiyan Zhu, et al.. (2025). Sodium aescinate induces hepatotoxicity through apoptosis and ferroptosis by inhibiting the Nrf2/CTH pathway. Journal of Ethnopharmacology. 345. 119608–119608. 1 indexed citations
4.
Lai, Hung‐Cheng, Chen Shu, Xiaofeng Luo, et al.. (2024). PRODH Regulates Tamoxifen Resistance through Ferroptosis in Breast Cancer Cells. Genes. 15(10). 1316–1316.
5.
Zhang, Mo, et al.. (2024). Short-chain fatty acids in fetal development and metabolism. Trends in Molecular Medicine. 31(7). 625–639. 7 indexed citations
6.
Xu, Wenhua, et al.. (2023). Arsenic up-regulates PD-L1 and enhances lung tumorigenesis through activation of STAT3 in alveolar epithelial type 2 cells. Toxicology and Applied Pharmacology. 482. 116787–116787. 3 indexed citations
7.
Liu, Yang, Guang‐Quan Mei, Jiajun Cui, et al.. (2023). Hexachlorocyclohexane impairs human sperm motility by affecting lysine glutarylation and mitochondrial functions. Food and Chemical Toxicology. 179. 113991–113991. 7 indexed citations
8.
Mei, Guang‐Quan, Yang Liu, Tao Luo, et al.. (2023). PCB126 impairs human sperm functions by affecting post-translational modifications and mitochondrial functions. Chemosphere. 346. 140532–140532. 3 indexed citations
9.
Cui, Jiajun, Wenhe Liu, Mingyu Zhao, et al.. (2023). Effects of different water and nitrogen treatments on greenhouse tomato yield, water use efficiency, and physiological responses. Irrigation Science. 42(3). 509–523. 2 indexed citations
10.
Li, Jiaqi, et al.. (2021). The mechanism underlying arsenic-induced PD-L1 upregulation in transformed BEAS-2B cells. Toxicology and Applied Pharmacology. 435. 115845–115845. 8 indexed citations
11.
Xu, Wenhua, Swagata Ghosh, Kai Qian, et al.. (2020). Defects of CTLA-4 Are Associated with Regulatory T Cells in Myasthenia Gravis Implicated by Intravenous Immunoglobulin Therapy. Mediators of Inflammation. 2020. 1–13. 12 indexed citations
12.
Yang, Yutao, Kai Qian, Lianlian Li, et al.. (2020). A novel tumor suppressor ZBTB1 regulates tamoxifen resistance and aerobic glycolysis through suppressing HER2 expression in breast cancer. Journal of Biological Chemistry. 295(41). 14140–14152. 19 indexed citations
13.
Zhang, Bingfeng, Lianlian Li, Kai Qian, et al.. (2019). Norcantharidin regulates ERα signaling and tamoxifen resistance via targeting miR-873/CDK3 in breast cancer cells. PLoS ONE. 14(5). e0217181–e0217181. 17 indexed citations
14.
Yang, Yutao, Jiajun Cui, Feng Xue, et al.. (2015). Resveratrol Represses Pokemon Expression in Human Glioma Cells. Molecular Neurobiology. 53(2). 1266–1278. 12 indexed citations
15.
Zhu, Min, Fan Zhang, Yutao Yang, et al.. (2014). FBI-1 Enhances ETS-1 Signaling Activity and Promotes Proliferation of Human Colorectal Carcinoma Cells. PLoS ONE. 9(5). e98041–e98041. 22 indexed citations
16.
Cui, Jiajun, Yifan Yang, Kai Qian, et al.. (2014). MiR-873 regulates ERα transcriptional activity and tamoxifen resistance via targeting CDK3 in breast cancer cells. Oncogene. 34(30). 3895–3907. 89 indexed citations
17.
Zhang, Chuanfu, Jiajun Cui, Qi Song, et al.. (2013). Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma. Oncology Reports. 31(2). 557–564. 18 indexed citations
18.
Zhang, Lijiang, et al.. (2013). Silencing MED1 Sensitizes Breast Cancer Cells to Pure Anti-Estrogen Fulvestrant In Vitro and In Vivo. PLoS ONE. 8(7). e70641–e70641. 18 indexed citations
19.
Cui, Jiajun, Tianying Wu, Jiang Wang, et al.. (2012). Cross-talk between HER2 and MED1 Regulates Tamoxifen Resistance of Human Breast Cancer Cells. Cancer Research. 72(21). 5625–5634. 88 indexed citations
20.
Cui, Jiajun, Yutao Yang, Chuanfu Zhang, et al.. (2010). FBI-1 functions as a novel AR co-repressor in prostate cancer cells. Cellular and Molecular Life Sciences. 68(6). 1091–1103. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lei Wan Breakdown of academic impact, for papers by Nan Jia Breakdown of academic impact, for papers by Xiaofei Zhang Breakdown of academic impact, for papers by Yihan Zhang Breakdown of academic impact, for papers by Ángeles Carlos‐Reyes Breakdown of academic impact, for papers by Sutapa Sinha Breakdown of academic impact, for papers by Jean‐Pierre Couty Breakdown of academic impact, for papers by Junrong Wang
Rankless by CCL
2026